Overview

Differential Mechanisms of Dyspnea Relief in Advanced COPD: Opiates vs. Bronchodilators

Status:
Suspended
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
Activity-related breathlessness (dyspnea) is the dominant symptom and persists despite optimal medical care in as many as 50% of patients with advanced chronic obstructive pulmonary disease (COPD). The objective of this project is to determine the underlying mechanisms of the activity-related breathlessness in patients with advanced COPD. To study the different pathways involved in causing breathlessness, we will compare the effects of two treatments, opiates with oxygen versus bronchodilators, which relieve breathlessness in different ways.
Phase:
Phase 4
Details
Lead Sponsor:
Queen's University
Collaborator:
Ontario Lung Association
Treatments:
Bronchodilator Agents
Citric Acid
Fentanyl
Ipratropium